Sort
261,768 grants matching “gene therapy”
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level
$847,474Anthony Rosenzweig · University Of Michigan At Ann Arbor · R35 · FY2023 · HL
Clinical efficacy of the antitumor agent ONC201 in GBM
$847,452Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2015 · CA
Mouse Models of FXTAS: Defining Critical Periods and Molecular Targets
$847,447Robert F Berman · University Of California At Davis · RL1 · FY2010 · NS
HBV cccDNA and integrated DNA in HIV coinfection and HBV monoinfection
$847,428Daryl T Lau · Beth Israel Deaconess Medical Center · R56 · FY2023 · AI
Methods development for "Omics" data
$847,292Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Human Respiratory Syncytial Virus Biology And Vaccine Development
$847,282Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis
$847,280Nicholas Eli Banovich · Translational Genomics Research Inst · R01 · FY2024 · HL
Understanding HIV-1 persistence and HIV-1-induced inflammation in tissues
$847,245Ya-Chi Ho · Yale University · R01 · FY2025 · AI
Nonhuman Primate
$847,213Michael K Axthelm · Oregon Health & Science University · P01 · FY2011 · AI
Functional genomic analysis of neural crest development
$847,181William J Pavan · National Human Genome Research Institute · ZIA · FY2016 · HG
Analysis of Dominant Megacolon: Another Hirschsprung Disease Model
$847,181William J Pavan · National Human Genome Research Institute · ZIA · FY2016 · HG
Mechanisms of Purkinje Cell Remodeling
$847,164Glenn I Fishman · New York University School Of Medicine · R01 · FY2025 · HL
Mechanisms of Purkinje Cell Remodeling
$847,164Glenn I Fishman · New York University School Of Medicine · R01 · FY2024 · HL
Center for the Study of Innate Immunity to HCV Infection
$847,117Michael J Gale · University Of Washington · U19 · FY2011 · AI
Resolving the cancer relevance of predisposition gene mutations
$847,111Fergus Joseph Couch · Mayo Clinic Rochester · R35 · FY2025 · CA
Molecular Biology of the Metastatic Phenotype
$847,050Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
$847,023Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2022 · NS
Personalized cancer models to discover and develop new therapeutic targets.
$847,023Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$847,016James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The AHR as a novel pathway for the induction of regulatory T cells
$847,000Nancy I Kerkvliet · Oregon State University · R01 · FY2010 · ES
Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint Immunotherapy
$846,982Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$846,976Francis W. Ruscetti · Basic Sciences · Z01 · FY2007 · CA
Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth
$846,976Francis W. Ruscetti · Basic Sciences · Z01 · FY2007 · CA
Genetic Prediction for Treatment Resistance in Kawasaki Disease
$846,959Michael A Portman · Seattle Children'S Hospital · R01 · FY2021 · HL
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population
$846,948Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R24 · FY2025 · OD